Revisto
AI-powered pharma marketing compliance
Indianapolis, Indiana, US
Revisto is an AI-powered platform specializing in automating Medical, Legal, and Regulatory (MLR) review for pharmaceutical and life sciences companies. The platform claims to cut review cycles by 90%, leading to estimated annual savings of $15 million or more per brand.
Source: HealthTechAlpha
HealthTechAlpha provided this information. To learn more and get deep data on all digital health companies, please visit them here.
Visit HealthTechAlpha →Problem Statement
Pharmaceutical and life sciences companies face time-consuming, error-prone Medical, Legal, and Regulatory (MLR) review processes.
Core Technology
AI and machine learning, continuously trained on FDA regulations (CFR 21) and global guidelines.
Key Differentiators
Integrates with Veeva Vault PromoMats
Company Info
- Business Model
- B2B SaaS
- Founded
- 2024
- Total Funding
- 6,000,000
- Website
- www.revisto.com/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Deployed with Big Pharma early adopters. Integrates real-time FDA 21 CFR regulations. Trained on proprietary terabytes of pharmaceutical marketing and clinical data.
MedStartr Index Score
?What do you think of Revisto?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.